本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Immunome Inc.

22.21
+0.20000.91%
盤後22.660.4492+2.02%19:34 EDT
成交量:61.52萬
成交額:1,364.67萬
市值:25.10億
市盈率:-9.44
高:22.42
開:22.13
低:21.61
收:22.01
52周最高:27.65
52周最低:8.67
股本:1.13億
流通股本:1.08億
量比:0.76
換手率:0.57%
股息:- -
股息率:- -
每股收益(TTM):-2.3519
每股收益(LYR):-2.4315
淨資產收益率:-50.14%
總資產收益率:-29.72%
市淨率:4.26
市盈率(LYR):-9.13

資料載入中...

2026/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/04

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]